Nephrotic syndrome in two haemophilia B children with inhibitor under low-dose immune tolerance induction combined with rituximab-based immunosuppressant protocol

被引：2
作者：
Li, Zekun [1 ,2 ,3 ]
Liu, Guoqing [1 ,2 ]
Yao, Wanru [1 ,2 ]
Chen, Zhenping [3 ]
Li, Gang [3 ]
Cheng, Xiaoling [4 ]
Zhen, Yingzi [1 ,2 ]
Ai, Di [1 ,2 ,3 ]
Huang, Kun [1 ,2 ,3 ]
Poon, Man-Chiu [5 ]
Wu, Runhui [1 ,2 ]
机构：
[1] Capital Med Univ, Beijing Key Lab Pediat Hematol Oncol, Natl Key Discipline Pediat, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Childrens Hosp, Natl Ctr Childrens Hlth, Haemophilia Comprehens Care Ctr,Hematol Ctr, 56 Nanlishi Rd, Beijing 100045, Peoples R China
[3] Capital Med Univ, Hematol Ctr,Beijing Pediat Res Inst,Beijing Key L, Natl Key Discipline Pediat,Beijing Childrens Hosp, Minist Educ,Natl Ctr Childrens Hlth,Haematol Dis, Beijing, Peoples R China
[4] Capital Med Univ, Natl Ctr Childrens Hlth, Haemophilia Comprehens Care Ctr, Pharmacol Dept,Beijing Childrens Hosp, Beijing, Peoples R China
[5] Univ Calgary, Southern Alberta Rare Blood & Bleeding Disorders, Pediat & Oncol,Cumming Sch Med, Foothills Hosp,Alberta Hlth Serv,Dept Med, Calgary, AB, Canada
来源：
HAEMOPHILIA | 2022年 / 28卷 / 02期
关键词：
REGISTRY;
D O I：
10.1111/hae.14471
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E42 / E45
页数：4
相关论文
共 10 条
  • [1] The B-Natural study-The outcome of immune tolerance induction therapy in patients with severe haemophilia B
    Astermark, Jan
    Holstein, Katharina
    Abajas, Yasmina L.
    Kearney, Susan
    Croteau, Stacy E.
    Liesner, Riana
    Funding, Eva
    Kempton, Christine L.
    Acharya, Suchitra
    Lethagen, Stefan
    LeBeau, Petra
    Bowen, Joel
    Berntorp, Erik
    Shapiro, Amy D.
    [J]. HAEMOPHILIA, 2021, 27 (05) : 802 - 813
  • [2] Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006)
    Chitlur, M.
    Warrier, I.
    Rajpurkar, M.
    Lusher, J. M.
    [J]. HAEMOPHILIA, 2009, 15 (05) : 1027 - 1031
  • [3] Cyclosporin A can achieve immune tolerance in a patient with severe haemophilia B and refractory inhibitors
    Cross, D. C. A.
    Van den Berg, H. M.
    [J]. HAEMOPHILIA, 2007, 13 (01) : 111 - 114
  • [4] DiMichele DM, 2002, THROMB HAEMOSTASIS, V87, P52
  • [5] Inhibitor development in haemophilia B: an orphan disease in need of attention
    DiMichele, Donna
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 138 (03) : 305 - 315
  • [6] Nephrotic syndrome as a complication of immune tolerance in hemophilia B
    Ewenstein, BM
    Takemoto, C
    Warrier, I
    Lusher, J
    Saidi, P
    Eisele, J
    Ettinger, LJ
    DiMichele, D
    [J]. BLOOD, 1997, 89 (03) : 1115 - 1116
  • [7] Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review
    Laros-van Gorkom, Britta Antonia Petra
    Falaise, Celine
    Astermark, Jan
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 93 : 26 - 38
  • [8] Inhibitor incidence in an unselected cohort of previously untreated patients with severe hemophilia B: a PedNet study
    Male, Christoph
    Andersson, Nadine G.
    Rafowicz, Anne
    Liesner, R. I.
    Kurnik, Karin
    Fischer, Kathelijn
    Platokouki, Helen
    Santagostino, Elena
    Chambost, Herve
    Nolan, Beatrice
    Koeigs, Christoph
    Kenet, Gili
    Ljung, Rolf
    van den Berg, H. Marijke
    [J]. HAEMATOLOGICA, 2021, 106 (01) : 123 - 129
  • [9] Tengborn L, 1998, HAEMOPHILIA, V4, P854
  • [10] Successful management of factor IX inhibitor-associated nephrotic syndrome in a hemophilia B patient
    Verghese, Priya
    Darrow, Stephen
    Kurth, Margaret H.
    Reed, Robyn C.
    Kim, Youngki
    Kearney, Susan
    [J]. PEDIATRIC NEPHROLOGY, 2013, 28 (05) : 823 - 826
1